Substance use disorder and the early course of illness in schizophrenia and affective psychosis.
about
Cannabis and psychiatric disorders: it is not only addictionSubstance use in clinical high risk for psychosis: a review of the literatureCannabis abuse and brain morphology in schizophrenia: a review of the available evidence.The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia?World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.Improving the quality of the cannabis debate: defining the different domains.Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.Adherence to medication regimens and participation in dual-focus self-help groupsThe Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.Comorbid substance abuse and brain morphology in recent-onset psychosisEndocannabinoid signaling in midbrain dopamine neurons: more than physiology?Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes.A qualitative study of career exploration among young adult men with psychosis and co-occurring substance use disorderInferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis.Is cannabis use a contributory cause of psychosis?Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment.Psychosocial Interventions in Reducing Cannabis Use in Early Phase Psychosis: A Canadian Survey of Treatments OfferedPredictors of psychosis remission in psychotic disorders that co-occur with substance useThe effectiveness of treatments for cocaine dependence in schizophrenic patients: a systematic review.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactatioComorbid substance abuse and neurocognitive function in recent-onset schizophrenia.Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review.Pharmacological treatment of schizophrenia with comorbid substance use disorder.Drug Dependence and Psychotic Symptoms: A Retrospective Study of Adolescents Who Abuse Drugs at Al-Amal Hospital in Jeddah, Saudi Arabia.The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis.Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia.Clinical correlates of early medication adherence: West London first episode schizophrenia study.Demographic and clinical correlates of substance abuse comorbidity in schizophrenia.Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD).Models of substance use in adolescents with and without psychosis.Lifetime history of substance misuse in first-episode psychosis: prevalence and its influence on psychopathology and onset of psychotic symptoms.Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms.Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features.Substance abuse co-morbidity in schizophrenia: An inpatient study of course and outcome.Light alcohol intake during adolescence induces alcohol addiction in a neurodevelopmental model of schizophrenia.Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis.The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.
P2860
Q22242611-0B91957C-9B3A-4AC9-AE42-BD2DED9250A2Q26859349-9F8EC256-322A-4A9A-AF72-73FBD5DE4E55Q30558464-339739DA-133B-4921-A2BC-2A94EC1F172EQ31149257-62650BB9-0627-48F1-89DB-B6661A4BEB95Q33223628-BF92E2BE-CA82-4B57-8D5E-8B977D9DCE48Q33799456-EF5ACF42-2EF9-488B-A0C3-6837036B7198Q33976751-B1D4235A-F2CD-432D-9442-7CA7ED91AB4BQ34116847-E78AFEEC-7C7E-4CCD-86F1-6A63B9BED8E8Q34531537-22E1EAD4-CFF2-45CD-BFE0-23507BE6719AQ34901749-6A59B6E6-4A0E-41D8-9666-270FD5D1D122Q34967151-60DDD6B5-C56C-46CE-B258-9A29C55C1F3FQ35136787-4925E50D-A679-4212-B4FE-AD6E737CA78FQ35759833-4DF542C5-F5AA-4E3D-97CF-6600D68A5A51Q36577094-5973DB37-B1E4-471E-9D6A-E3A3846BE92EQ36606244-307AB25D-1B47-41C1-A069-369E748F6409Q36618852-D502A070-D753-4DBD-ABFE-65E3AAFFF958Q36914975-F526BBEA-4EBF-4348-9408-776D794E673FQ37075954-3113DDAF-5326-4392-B667-312D679CAD78Q37149014-BCF6C184-75DB-47A9-8971-DFD4F8712248Q38395937-213BFAD6-EDC0-488F-8048-37356AFE4037Q38401669-1D6C8872-4270-4159-89F8-36A054B83ADCQ38618558-AD9FC337-75DF-46E3-AA50-B58A6F939A17Q38658672-30F15536-50A7-49CA-990A-495B3CCC7237Q38904740-F420004F-CCF6-4BD0-8FE0-3133D3F2DA4FQ38960232-00A7A594-9C09-40C4-BB2B-5905F1099EF0Q39126835-AEE37DCF-277A-4877-83FD-07FF43784B13Q39340879-7A99CB13-2588-4C57-B939-BDEF442D5D76Q40549838-5CEFEF4F-BA3D-4BD4-B387-DF213D35DE02Q41823549-319663E9-D30A-42E7-B832-B1D381F4E406Q43117994-AE50F48D-781D-4496-977D-6FD17E8F0C24Q43242387-175C8089-8D3F-4799-9FF2-92F3AD8C8F36Q43808532-8505C701-30DD-4CD3-A21F-6163058A9DA7Q45049153-FBC4E22A-C48D-4CD5-A462-5ECB8940BFA1Q45070768-9F1F8510-78D4-46A2-9094-D1507C7E2E53Q46544986-B46F4A70-F6DA-479A-9505-240F83B335B8Q47780196-E21F50D1-B354-410D-899B-8F68F8C41B12Q51914949-EB384A6F-36F6-4787-B3F4-8901647B6BDFQ52861250-B21C40A4-DCEE-4EE2-9382-F4BACE8C32E6
P2860
Substance use disorder and the early course of illness in schizophrenia and affective psychosis.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Substance use disorder and the ...... renia and affective psychosis.
@en
Substance use disorder and the ...... renia and affective psychosis.
@nl
type
label
Substance use disorder and the ...... renia and affective psychosis.
@en
Substance use disorder and the ...... renia and affective psychosis.
@nl
prefLabel
Substance use disorder and the ...... renia and affective psychosis.
@en
Substance use disorder and the ...... renia and affective psychosis.
@nl
P2093
P356
P1476
Substance use disorder and the ...... renia and affective psychosis.
@en
P2093
Fleischer J
Kovasznay B
Tanenberg-Karant M
P304
P356
10.1093/SCHBUL/23.2.195
P407
P577
1997-01-01T00:00:00Z